| Abstrakt: |
A recent study conducted at the Affiliated Hospital of Southwest Medical University aimed to uncover the biological mechanisms underlying the effectiveness of electroconvulsive therapy (ECT) in treating schizophrenia. The study analyzed mRNA sequencing data from eight patients before and after ECT, as well as eight healthy controls. The researchers found that genes associated with the efficacy of ECT were primarily enriched in neurotrophin, mitogen-activated protein kinase, and long-term potentiation signaling pathways. This research provides valuable insights into the molecular mechanisms of ECT in schizophrenia treatment. [Extracted from the article] |
